GEMOX: An Active Regimen for the Treatment of Luminal and Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer

Publisher: Karger

E-ISSN: 1421-9794|62|1|30-33

ISSN: 0009-3157

Source: Chemotherapy, Vol.62, Iss.1, 2016-06, pp. : 30-33

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content